Current concepts in aesthetic endocrinology

Gynecological Endocrinology

Volumn 16, Issue 6, 2002, Pages 431-441

  Gruber, C J ^a   Wieser, F ^b   Gruber, I M L ^b   Ferlitsch, K ^b   Gruber, D M ^b   Huber, J C ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Acne; Aesthetic Endocrinology; Body Composition; Cellulite; Skin Aging

Indexed keywords

ANDROSTANOLONE; CONJUGATED ESTROGEN; ESTRADIOL VALERATE; ESTROGEN; FINASTERIDE; MINOXIDIL; NORETHISTERONE ACETATE; PLACEBO; STEROID;

ACNE; AGING; ARTICLE; BODY COMPOSITION; ENDOCRINOLOGY; ESTHETICS; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; PRIORITY JOURNAL; STEROID METABOLISM; SUBSTITUTION THERAPY; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; WELLBEING;

EID: 0036966372     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.16.6.431.441     Document Type: Article

References (66)

1. Fantl JA, Cardozo L, McClish D, and the Hormones and Urogenital Therapy Committee. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 1994;83:12-18
2. Sator MO, Gruber DM, Joura EA. Hormonal influences on intraocular pressure. Lancet 1996;348:761-2
3. Metka M, Heytmanek G, Enzelsberger H, et al. Der Gelenkschmerz in der Prä- und Postmenopause: Arthropathia climacterica. Geburtsch u Frauenheilk 1988;48:232-4
4. Fillit H, Luine V. The neurobiology of gonadal hormones and cognitive decline in late life. Maturitas 1997;26:159-64
5. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and action of estrogens. N Engl J Med 2002;346:340-52
6. Wang Q, Hassager C, Ravn P, et al. Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related? Am J Clin Nutr 1994;60:843-8
7. Aloia JF, Vaswani A, Russo L, et al. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995;172:896-900
8. Stumpf WE, Koike N, Hayakawa K, et al. Distribution of 1,25-dihydroxyvitamin D3(22-ox), in vivo receptor binding in adult and developing skin. Arch Dermatol Res 1995;278:294-303
9. Misra PB, Nickoloff BJ, Morhenn VB, et al. Characterisation of insulin-like growth factor-1/somatomedin-C receptors on human keratinocyte monolayers. J Invest Dermatol 1986;87:265-73
10. Hasselquist MB, Goldberg N, Schroeter A, Spelsberg TC. Isolation and characterisation of the estrogen receptor in human skin. J Clin Endocrinol Metab 1980;50:76-82
11. Nickoloff BJ, Misra PB, Morhenn VB, et al. Further characterisation of keratinocyte somatomedin C/insulin-like growth factor (SM-C/IGF-1) receptor and the biological responsiveness of cultured keratinocytes to SM-S/IGF-1. Dermatologic 1988;117:265-73
12. Marx PA, Spira AI, Gettie AM, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996;10:1084-9
13. Murray JC. Pregnancy and the skin. Dermatol Clin 1990;8:327-34
14. Smith AG, Shuster S, Thody AF. Chloasma, oral contraceptives, and plasma immune reactive beta-melanocytic-stimulating hormone. J Invest Dermatol 1977;68:169-70
15. Roop D. Defects in the barrier. Science 1995;267:474-5
16. Grosman N. Studies on the hyaluronic acid protein complex, the molecular size of hyaluronic acid and the exchangeability of chloride in skin of mice before and after oestrogen treatment. Acta Pharmacol Toxicol 1973;33:201-8
17. Hassager C, Jensen LT, Podenphant J, et al. Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones. Metabolism 1990;39:1167-9
18. Grosman N, Hirdberg E, Schon J. The effect of oestrogenic treatment of the acidmucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol 1971;30:359-64
19. Simon C, Gimeno MJ, Mercader A. Cytokines adhesion molecules - invasive proteinases. The missing paracrine/autocrine link in embryonic implantation. Mol Hum Reprod 1996;2:405-24
20. Sato T, Ito A, Mori Y. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases by progesterone and oestradiol-17β. Biochem J 1991;275:645-50
21. Van der Burg B, Van der Saag PT. Nuclear factor-kappa-B/steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol Hum Reprod 1996;2:433-8
22. Fisher GJ, Wang ZQ, Datta SD, et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997;337:1419-28
23. Schmidt JB, Binder M, Demschik G, et al. Treatment of skin aging with topical estrogens. Int J Dermatol 1996;35:669-74
24. Creidi P, Faivre B, Agache P, et al. Effect of conjugated oestrogen (Premarin®) cream on ageing facial skin. A comparative study with a placebo cream. Maturitas 1994;19:211-23
25. Brincat M, Moniz CJ, Studd JWW. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92:256-9
26. Brincat M, Versi E, Moniz CF. Skin collagen changes in postmenopausal women receiving two different regimen oestrogen therapy. Obstet Gynecol 1987;70:123-7
27. Brincat M, Moniz CF, Studd JWW. Sex hormones and skin collagen content in postmenopausal women. Br Med J 1983;187:1337-8
28. Haapasaari KM, Raudaskoski T, Kallioinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997;27:153-62
29. Formosa M, Brincat MP, Cardozo LD, Studd JWW. Collagen, the significance in skin, bones and bladder. In Lobo RA, ed. Treatment of the Postmenopausal Woman. Basic and Clinical Aspects. New York, Raven Press, 1994:143-51
30. Bardin CW, Lipsett MB. Testosterone and androstenedione blood production rates in normal women and women with idiopatic hirsutism or polycystic ovaries. J Clin Invest 1967;46:891-7
31. Carmina E, Lobo RA. Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J Clin Encodrincol Metab 1993;76:1111-4
32. Strauss JS, Klingman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol 1962;82:779-90
33. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 1994;63:25-61
34. Mauvais-Jarvis P. Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women. Clin Endocrinol Metab 1986;15:307-17
35. Serafini P, Lobo RA. Increased 5α-reductase activity in idiopatic hirsutism. Fertil Steril 1985;43:74-8
36. Bergfeld WF. Etiology and diagnosis of androgenetic alopecia. Clin Dermatol 1988;6:102-7
37. Lynfield YL. Effect of pregnancy on the human hair cycle. J Invest Dermatol 1960;55:323-7
38. Paulson RJ, Serafini PC, Catalino JA, Lobo RA. Measurements of 3α, 17β-androstenediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity. Fertil Steril 1986;46:222-6
39. Nielsen TA, Reichel M. Alopecia: diagnosis and management. Am Fam Physician 1995;51:1513-22
40. Strauss JS, Rapini RP, Shalita AR. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984;10:490-6
41. Chalker DK, Lesher JK Jr, Smith JG. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation. J Am Acad Dermatol 1987;17:251-4
42. Leyden JJ, Marples RR, Mills OH, Klingman AM. Tretinoin and antibiotic therapy in acne vulgaris. South Med J 1974;67:20-5
43. Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride: effect of food, milk, and iron. J Am Acad Dermatol 1985;12:308-12
44. Strauss JS, Pochi PE. The effect of cyclic progestagen-estrogen therapy on sebum and acne in women. J Am Med Assoc 1964;190:815-9
45. Muhlemann MF, Carter GD, Cream JJ. Oral spironolactone: an effective treatment of acne vulgaris in women. Br J Dermatol 1986;115:227-32
46. Hammerstein J, Meckies J, Leo-Rossberg I, et al. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism, and virilism. J Steroid Biochem 1975;6:827-36
47. Gruber DM, Sator MO, Joura EA, et al. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial. Arch Dermatol 1998;134:459-63
48. Lobo RA, Shoupe D, Serafini P, et al. The effects of two doses of spironolactone of serum androgens and anagen hair in hirsute women. Fertil Steril 1985;43:200-5
49. Barth JH, Cherry CA, Wojnarowska F, Dawber RPR. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for hirsute women. J Clin Endocrinol Metab 1989;68:966-70
50. Adashi EY. Potential utility of gonadotropin-releasing hormone agonist in the management of ovarian hyperandrogenism. Fertil Steril 1990;53:765-79
51. Price DM, Allen S, Pegram GV. Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone. Fertil Steril 2000;74:414-5
52. Tolino A, Petrone A, Sarnacchiaro F, et al. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril 1996;66:61-5
53. Ciotta L, Cianci A, Calogero A, Palumbo LA. Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism. Fertil Steril 1995;64:299-306
54. DeVillez RK, Jacobs JB, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol 1994;130:303-7
55. Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 1993;32:758-62
56. Borkan GA, Hults DE, Gerzof SG, et al. Age changes in body composition revealed by computer tomography. J Gerontol 1983;38:673-7
57. Ley CJ, Lee B, Stevenson JC. Sex and menopause - associated changes in body fat distribution. Am J Clin Nutr 1992;55:950-4
58. Longcope C. Androgen and estrogen conversion ratios in aging women. Maturitas 1979;2:13-17
59. Rebuffé-Scrive M, Basdevant A, Guy-Grand B. Effect of local application of progesterone on human adipose tissue lipoprotein lipase. Horm Metab Res 1083;15:566-71
60. Eckel RH. Lipoprotein lipase - a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989;320:1060-8
61. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323-6
62. Marin P, Holmang S, Jonsson L, Sjostrom L. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obesity 1992;16:991-7
63. Lovejoy JC, Bray GA, Bourgeois MO, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 1996;81:2198-203
64. Nürnberger F, Müller G. So-called cellulite: an invented disease. J Dermatol Surg Oncol 1978;4:221-9
65. Nürnberger F, Riedel-Pauls W, Gräf KJ, et al. Status protrusus cutis und sexual hormone beim Klinefelter-Syndrom. Z Hautkr 1979;54:47-57
66. Gruber DM, Sator MO, Kirchengast S, et al. Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women. Maturitas 1998;29:253-9